LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $206,000 | -13.8% | 995 | -31.1% | 1.67% | +15.1% |
| Q1 2018 | $239,000 | +20.7% | 1,445 | 0.0% | 1.45% | +16.7% |
| Q4 2017 | $198,000 | +0.5% | 1,445 | 0.0% | 1.24% | +245.6% |
| Q3 2017 | $197,000 | +12.6% | 1,445 | 0.0% | 0.36% | +8.4% |
| Q2 2017 | $175,000 | +14.4% | 1,445 | 0.0% | 0.33% | +7.1% |
| Q1 2017 | $153,000 | +4.1% | 1,445 | 0.0% | 0.31% | -0.6% |
| Q4 2016 | $147,000 | -99.9% | 1,445 | 0.0% | 0.31% | +51.5% |
| Q3 2016 | $147,476,000 | +85641.9% | 1,445 | 0.0% | 0.21% | +46.1% |
| Q2 2016 | $172,000 | -99.9% | 1,445 | -33.9% | 0.14% | -4.7% |
| Q1 2016 | $233,991,000 | +98630.4% | 2,185 | 0.0% | 0.15% | +3.5% |
| Q4 2015 | $237,000 | +24.1% | 2,185 | -2.2% | 0.14% | +6.7% |
| Q3 2015 | $191,000 | +30.8% | 2,235 | +54.7% | 0.13% | +52.3% |
| Q2 2015 | $146,000 | – | 1,445 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |